Product custom-nanocomposites-lipid-nanoparticle-composite-materials

Home > products > custom-nanocomposites> lipid-nanoparticle-composite-materials

Catalog	name	Description	price
R-R-5733	Doxorubicin liposomes for post-insertion (non-PEGylated)	Doxorubicin is a widely used chemotherapeutic agent that has been formulated into liposomal drug delivery systems to enhance its therapeutic efficacy while reducing systemic toxicity. Liposomes are spherical vesicles composed of lipid bilayers that can encapsulate hydrophilic and hydrophobic drugs. Non-PEGylated doxorubicin liposomes represent a specific formulation that does not utilize polyethylene glycol (PEG) to modify the liposomal surface.	price>
R-R-5734	Preformed Doxorubicin Liposomes(HSPC :Cholesterol)(60:40 molar ratio)	Preformed doxorubicin liposomes are an advanced formulation designed to deliver the chemotherapeutic agent doxorubicin in a manner that enhances its efficacy and reduces systemic toxicity. The specific liposomal formulation described comprises HSPC (hydrogenated soy phosphatidylcholine) and cholesterol in a 60:40 molar ratio, which plays a critical role in defining the physiochemical properties and performance of the liposomes.	price>
R-R-5735	Surface Reactive Doxorubicin Liposomes-Cyanur (PEGylated)	Surface reactive doxorubicin liposomes with cyanur and PEGylation represent a significant advancement in the field of targeted cancer therapy. This formulation aims to enhance the therapeutic properties of doxorubicin while minimizing toxicity, thus contributing to improved treatment outcomes for cancer patients. Ongoing research in this area continues to refine liposomal formulations, optimize targeting capabilities, and evaluate their effectiveness in clinical settings.	price>
R-M1-cs8797	ROS responsive liposomes loaded with CE6+ML385+L-arginine	By combining these three components (CE6, ML385, and L-arginine) within ROS responsive liposomes, it is possible to create a targeted drug delivery system that responds to specific oxidative conditions found in the body. The release of the cargo can be triggered by ROS, leading to local therapeutic effects.	price>
R-M1-cs8798	ROS responsive liposomes loaded with CE6+ML385	The combination of CE6 and ML385 in ROS responsive liposomes can be particularly useful in targeting and treating diseases or conditions characterized by high ROS levels, such as certain cancers, inflammatory disorders, and oxidative stress-related diseases.	price>
R-M2-9508	PLGA-imatinib nanoparticles	PLGA-imatinib nanoparticles can be used as a formulation for treating CML and GISTs, improving drug efficacy and reducing side effects associated with systemic administration.They can potentially be used to co-deliver other chemotherapeutics or radiosensitizers, allowing for synergistic effects in cancer treatment.	price>
R-M2-9881	Ultrasonic microbubble lipid material	Ultrasonic microbubble lipid material is a perfluoroalkyl micro ultrasound contrast agent. Ultrasound microbubbles are a type of microsphere structure containing gas, typically composed of gas cores wrapped in biocompatible materials, with a diameter typically between 1-10 micrometers. These microbubbles were initially developed in the medical field as ultrasound contrast agents (UCA) to enhance the contrast and clarity of ultrasound imaging. With the deepening of research, it has been discovered that the unique physical effects generated by microbubbles under ultrasound can temporarily increase the permeability of cell membranes and tissues, which promotes the application of ultrasound microbubbles in drug delivery and beauty fields.	price>
R-M2-9969	PLGA5K (50/50)-PEG2k-TPP nanoparticles encapsulating resveratrol	PLGA5K (50/50)-PEG2k-TPP nanoparticles encapsulating resveratrol is a functionalized nanocarrier that is expected to improve the delivery efficiency and therapeutic effect of resveratrol through the mitochondrial targeting ability of TPP.This design has significant application value in the fields of drug delivery and biomedical engineering.	price>
R-M2-10260	Liposomal encapsulation Prussian blue nanoparticles and atorvastatin	Liposomal encapsulation Prussian blue nanoparticles and atorvastatin is a multifunctional nano delivery system combining imaging function and therapeutic potential, which can be used for integrated research on diagnosis and treatment of atherosclerosis, tumor or inflammatory diseases.	price>
R-M1-8676	Blank Lipid nanoparticles-GIn(100nm)	Blank lipome nanoparticles-GIn/Blank liposome nanoparticles-GIn(100nm) can be used for drug loading, drug delivery and targeted cell research.	price>

...